A C Howlett - JoVE Visualize

Showing results (61-70 of 74) with videos related to

Pageof 8

Sort By:

The Journal of Pharmacology and Experimental Therapeutics|February 25, 2000

D(2), but not D(1) dopamine receptor agonists potentiate cannabinoid-induced sedation in nonhuman primatesJ P Meschler, F A Clarkson, P J Mathews, et al.

Drug Design and Discovery|November 1, 1995

Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activityL S Melvin, G M Milne, M R Johnson, et al.

Prostaglandins, Leukotrienes, and Essential Fatty Acids|October 17, 1998

Structural requirements for arachidonylethanolamide interaction with CB1 and CB2 cannabinoid receptors: pharmacology of the carbonyl and ethanolamide groupsB A Berglund, D L Boring, G H Wilken, et al.

Trends in Neurosciences|October 1, 1990

The cannabinoid receptor: biochemical, anatomical and behavioral characterizationA C Howlett, M Bidaut-Russell, W A Devane, et al.

Molecular Pharmacology|November 1, 1993

Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogsL S Melvin, G M Milne, M R Johnson, et al.

Brain Research|April 1, 1991

Chronic exposure to delta 9-tetrahydrocannabinol fails to irreversibly alter brain cannabinoid receptorsT M Westlake, A C Howlett, S F Ali, et al.

Journal of Neurochemistry|May 9, 2000

Azido- and isothiocyanato-substituted aryl pyrazoles bind covalently to the CB1 cannabinoid receptor and impair signal transductionA C Howlett, G H Wilken, J J Pigg, et al.

The Journal of Biological Chemistry|September 16, 1994

Inhibitors of arachidonoyl ethanolamide hydrolysisB Koutek, G D Prestwich, A C Howlett, et al.

Drug Design and Discovery|May 12, 2000

Development of a novel class of monocyclic and bicyclic alkyl amides that exhibit CB1 and CB2 cannabinoid receptor affinity and receptor activationB A Berglund, P R Fleming, K C Rice, et al.

Journal of Medicinal Chemistry|November 7, 1998

Three-dimensional quantitative structure-activity relationship study of the cannabimimetic (aminoalkyl)indoles using comparative molecular field analysisJ Y Shim, E R Collantes, W J Welsh, et al.

Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:

Pageof 8

The Journal of Pharmacology and Experimental Therapeutics|February 25, 2000

D(2), but not D(1) dopamine receptor agonists potentiate cannabinoid-induced sedation in nonhuman primatesJ P Meschler, F A Clarkson, P J Mathews, et al.

Drug Design and Discovery|November 1, 1995

Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activityL S Melvin, G M Milne, M R Johnson, et al.

Prostaglandins, Leukotrienes, and Essential Fatty Acids|October 17, 1998

Structural requirements for arachidonylethanolamide interaction with CB1 and CB2 cannabinoid receptors: pharmacology of the carbonyl and ethanolamide groupsB A Berglund, D L Boring, G H Wilken, et al.

Trends in Neurosciences|October 1, 1990

The cannabinoid receptor: biochemical, anatomical and behavioral characterizationA C Howlett, M Bidaut-Russell, W A Devane, et al.

Molecular Pharmacology|November 1, 1993

Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogsL S Melvin, G M Milne, M R Johnson, et al.

Brain Research|April 1, 1991

Chronic exposure to delta 9-tetrahydrocannabinol fails to irreversibly alter brain cannabinoid receptorsT M Westlake, A C Howlett, S F Ali, et al.

Journal of Neurochemistry|May 9, 2000

Azido- and isothiocyanato-substituted aryl pyrazoles bind covalently to the CB1 cannabinoid receptor and impair signal transductionA C Howlett, G H Wilken, J J Pigg, et al.

The Journal of Biological Chemistry|September 16, 1994

Inhibitors of arachidonoyl ethanolamide hydrolysisB Koutek, G D Prestwich, A C Howlett, et al.

Drug Design and Discovery|May 12, 2000

Development of a novel class of monocyclic and bicyclic alkyl amides that exhibit CB1 and CB2 cannabinoid receptor affinity and receptor activationB A Berglund, P R Fleming, K C Rice, et al.

Journal of Medicinal Chemistry|November 7, 1998

Three-dimensional quantitative structure-activity relationship study of the cannabimimetic (aminoalkyl)indoles using comparative molecular field analysisJ Y Shim, E R Collantes, W J Welsh, et al.

Pageof 8